Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant

Bone Marrow Transplantation

Volumn 27, Issue 1, 2001, Pages 53-64

  Regn, S ^a   Raffegerst, S ^a   Chen, X ^a   Schendel, D ^a   Kolb, H J ^a   Roskrow, M ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Adenovirus; Allogeneic stem cell transplantation; CTL; EBV; Lymphoblastoid cell line

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CD40 ANTIGEN; CHROMIUM 51; LIGAND; LIPID;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; DONOR; EPSTEIN BARR VIRUS; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMATURITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOBLASTOID CELL LINE; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; NORMAL HUMAN; PATIENT; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROPHYLAXIS; TARGET CELL DESTRUCTION; VIRUS INFECTION;

ADENOVIRIDAE; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BONE MARROW TRANSPLANTATION; CELL CULTURE TECHNIQUES; COCULTURE TECHNIQUES; DENDRITIC CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS; VIRUSES;

EID: 0035141371     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702752     Document Type: Article

References (38)

1. The Epstein-Barr virus and the immune system
2. Adenovirus infection after pediatric bone marrow transplantation
3. Epstein-Barr virus-associated B-cell lymphoproliferative disorders following bone marrow transplantation
4. Epstein-Barr virus lymphoproliferation after bone marrow transplantation
5. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
6. Semiquantitative Epstein-Barr virus-(EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation
7. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantion
8. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T-lymphocytes
9. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus related lymphoproliferation
10. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
11. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein
12. Antigen presentation by EBV-B cells to resting and activated T cells: Role of interleukin 1
13. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cells in vitro
14. Extensive cross-reactivity of adenovirus-specific cytotoxic T-cells
15. Increasing incidence of adenovirus disease in bone marrow transplant recipients
16. The biology of Epstein-Barr virus: Lessons learned from the virus and the host
17. Viruses, host-responses, and autoimmunity
18. Characterization of human proliferative T cell responses to adenovirus
19. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation
20. Human pathogen subversion of antigen presentation
21. Interference with antigen processing by viruses
22. Immune responses to adenoviruses: Viral evasion mechanisms and their implications for the clinic
23. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
24. + dendritic cells
25. Proliferating dendritic cell progenitors in human blood
26. Dendritic cells and the control of immunity
27. The dendritic cell system and its role in imunogenicity
28. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL
29. Immunization with human papillomavirus type 16 (HPV 16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I restricted protection to HPV-16 induced tumor cells
30. Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
31. Genetic immunization for the melanoma antigen MART-1/melan-A using recombinant adenovirus transduced murine dendritic cells
32. Bone-marrow generated dendritic cells pulsed with a class-I restricted peptide are potent inducers of cytotoxic T lymphocytes
33. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
34. Upregulation of integrins αvβ3 and αvβ5 on human monocytes and T-lymphocytes facilitates adenovirus-mediated gene delivery
35. 5 promote adenovirus internalization but not virus attachment
36. v integrins for infection
37. Get into the groove! Targeting antigens to MHC class II
38. Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies